Jill Buck
CIK 1780426 · Chief Development Officer · last filed 2026-02-03
Jill Buck is a Chief Development Officer who has filed 6 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for ENGNW, was dated Feb 3, 2026. Across all open-market trades the lifetime net is −$214.1K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
6
-$214.1K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ENGNW | Chief Development Officer | — | $0.27 | — | $0 | 2 | 2026-02-03 |
| Alaunos Therapeutics, Inc. (ZIOP) Delisted | EVP, GM Gene Therapy | 231,016 | $0.87 | $200.0K | -$214.1K | 4 | 2021-03-08 |
Recent Filings
6 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-03 | ENGNW | Grant (A) | — | $0 | EDGAR |
| 2025-07-10 | ENGNW | Grant (A) | — | $0 | EDGAR |
| 2021-03-08 | Alaunos Therapeutics, Inc. (ZIOP) Delisted | Grant (A) | +31,500 | $0 | EDGAR |
| 2021-01-12 | Alaunos Therapeutics, Inc. (ZIOP) Delisted | Sell (S) | −27,894 | -$87.0K | EDGAR |
| 2020-01-31 | Alaunos Therapeutics, Inc. (ZIOP) Delisted | Grant (A) | +53,700 | $0 | EDGAR |
| 2020-01-03 | Alaunos Therapeutics, Inc. (ZIOP) Delisted | Sell (S) | −27,923 | -$127.0K | EDGAR |